While it was a simplification of the facts, on the other side we have to remember there is no guarantee anything will be sold, let alone cash received, this quarter.
For example:
Around 1 year ago an infusion deal was imminent. Still waiting
TGA approval was expected two quarters ago. Still waitng.
Europe approval... still waiting.
TAVR update.....
So, while it is possible that this quarter will be a ripper with a TAVR update, infusion sale, immunotherapy deal, TGA approval, Europe etc. It is also possible it will be like last quarter. Radio silence. I am a little concerned that there appears a deliberate shift to avoid announcing anything, the company has gone from announcing every little thing they could to reporting as little as humanly possible.
Who knows anymore. These levels are certainly cheap. Worth a punt for some I'm sure.
While it was a simplification of the facts, on the other side we...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.13 |
Change
-0.220(1.20%) |
Mkt cap ! $348.5M | |||
| Open | High | Low | Value | Volume |
| $18.36 | $18.47 | $18.13 | $30.44K | 1.674K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.35 | 55 | 3 |
View Market Depth
| Last trade - 10.36am 03/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |